MYD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Myriad Genetics Inc

Watchlist Manager

Watchlist

Price: 4.935 EUR 2.43% Market Closed

Market Cap: €443.7m

M	Myriad Genetics Inc XHAM:MYD	US
D	Despegar.com Corp F:D3G	AR
	Red 5 Ltd ASX:RED	AU
H	Henry Schein Inc XBER:HS2	US
	Tauron Polska Energia SA F:1T5	PL
G	Gran Tierra Energy Inc F:G1P	CA
	Graines Voltz SA PAR:GRVO	FR
A	Archrock Inc XBER:54E	US
	Gold Fields Ltd F:EDG	ZA
M	Mainova AG XBER:MNV6	DE
P	PPC Ltd JSE:PPC	ZA
L	Lucara Diamond Corp SWB:LKT	CA
M	MariaDB PLC NYSE:MRDB	IE

Profitability Summary

Myriad Genetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

68% > 70%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-26% > -8%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-32%

Declining Net Margin

-36% > -48%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-11%

Free Cash Flow Margin is Increasing

-17% > -3%

Negative ROE

-77%

Negative 3Y Average ROE

Negative 3Y Average ROIC